These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2048055)

  • 1. Effect of picotamide on platelet aggregation and on thromboxane A2 production in vivo.
    Minuz P; Lechi C; Arosio E; Guzzo P; Zannoni M; Lauciello C; Lechi A
    Thromb Haemost; 1991 Mar; 65(3):312-6. PubMed ID: 2048055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.
    Weber C; Beetens JR; Tegtmeier F; Van Rooy P; Vercammen E; Wouters L; De Clerck F
    Thromb Haemost; 1992 Aug; 68(2):214-20. PubMed ID: 1412169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prostacyclin-sparing effect of indobufen vs. aspirin.
    De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
    Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo.
    Bode-Böger SM; Böger RH; Kienke S; Böhme M; Phivthong-ngam L; Tsikas D; Frölich JC
    Cardiovasc Res; 1998 Mar; 37(3):756-64. PubMed ID: 9659460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of a thrombin inhibitor and a platelet GP IIb/IIIa antagonist in vivo: evidence that thrombin mediates platelet aggregation and subsequent thromboxane A2 formation during coronary thrombolysis.
    Pratico D; Murphy NP; Fitzgerald DJ
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1178-85. PubMed ID: 9190851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets.
    Gresele P; Deckmyn H; Arnout J; Nenci GG; Vermylen J
    Thromb Haemost; 1989 Jun; 61(3):479-84. PubMed ID: 2552606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by picotamide of thromboxane production in vitro and ex vivo.
    Violi F; Ghiselli A; Iuliano L; Praticò D; Alessandri C; Balsano F
    Eur J Clin Pharmacol; 1988; 33(6):599-602. PubMed ID: 3366163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
    Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
    Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
    Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
    Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
    Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism.
    Vezza R; Spina D; Tallarida RJ; Nathan M; Page CP; Gresele P
    Thromb Haemost; 1997 Nov; 78(5):1385-91. PubMed ID: 9408024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt.
    Adatia I; Barrow SE; Stratton PD; Ritter JM; Haworth SG
    Br Heart J; 1994 Nov; 72(5):452-6. PubMed ID: 7818962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of short-term diets rich in fish, red meat, or white meat on thromboxane and prostacyclin synthesis in humans.
    Mann N; Sinclair A; Pille M; Johnson L; Warrick G; Reder E; Lorenz R
    Lipids; 1997 Jun; 32(6):635-44. PubMed ID: 9208393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction.
    D'Andrea G; Perini F; Hasselmark L; Alecci M; Cananzi AR
    Funct Neurol; 1995; 10(2):91-8. PubMed ID: 7557557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antiestrogen regimen on prostacyclin and thromboxane A2 in postmenopausal patients with breast cancer: evidence of significance of hypertension, smoking or previous use of estrogen therapy.
    Marttunen MB; Pyrhönen S; Tiitinen AE; Viinikka LU; Ylikorkala O
    Prostaglandins; 1996 Oct; 52(4):317-26. PubMed ID: 8936586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression.
    Gresele P; Corona C; Alberti P; Nenci GG
    Thromb Haemost; 1990 Aug; 64(1):80-6. PubMed ID: 2274931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.